BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 20388624)

  • 21. Influence of a new hydroxyethylstarch preparation (HES 130/0.4) on coagulation in cardiac surgical patients.
    Haisch G; Boldt J; Krebs C; Suttner S; Lehmann A; Isgro F
    J Cardiothorac Vasc Anesth; 2001 Jun; 15(3):316-21. PubMed ID: 11426361
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perioperative volume effect of HES 120/0.7 compared with dextran 70 and Ringer acetate.
    Hiippala S; Teppo AM
    Ann Chir Gynaecol; 1996; 85(4):333-9. PubMed ID: 9014063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery.
    Haisch G; Boldt J; Krebs C; Kumle B; Suttner S; Schulz A
    Anesth Analg; 2001 Mar; 92(3):565-71. PubMed ID: 11226079
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxyethyl starch impairs in vitro coagulation.
    Niemi TT; Kuitunen AH
    Acta Anaesthesiol Scand; 1998 Oct; 42(9):1104-9. PubMed ID: 9809097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro effects of different medium molecular hydroxyethyl starch solutions and lactated Ringer's solution on coagulation using SONOCLOT.
    Konrad CJ; Markl TJ; Schuepfer GK; Schmeck J; Gerber HR
    Anesth Analg; 2000 Feb; 90(2):274-9. PubMed ID: 10648306
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses.
    Kasper SM; Meinert P; Kampe S; Görg C; Geisen C; Mehlhorn U; Diefenbach C
    Anesthesiology; 2003 Jul; 99(1):42-7. PubMed ID: 12826840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation.
    Boldt J; Haisch G; Suttner S; Kumle B; Schellhaass A
    Br J Anaesth; 2002 Nov; 89(5):722-8. PubMed ID: 12393770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hydroxyethyl starch and modified fluid gelatin maintain plasma volume in a porcine model of septic shock with capillary leakage.
    Marx G; Cobas Meyer M; Schuerholz T; Vangerow B; Gratz KF; Hecker H; Sümpelmann R; Rueckoldt H; Leuwer M
    Intensive Care Med; 2002 May; 28(5):629-35. PubMed ID: 12029413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Rotational thromboelastometry assessment of ballanced crystalloid, hydroxyethyl starch and gelatin effects on coagulation: a randomized trial].
    Sevcikova S; Durila M; Vymazal T
    Braz J Anesthesiol; 2019; 69(4):383-389. PubMed ID: 31405567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombelastographic whole blood clot formation after ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate.
    Fenger-Eriksen C; Anker-Møller E; Heslop J; Ingerslev J; Sørensen B
    Br J Anaesth; 2005 Mar; 94(3):324-9. PubMed ID: 15608046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery.
    Lang K; Boldt J; Suttner S; Haisch G
    Anesth Analg; 2001 Aug; 93(2):405-9 , 3rd contents page. PubMed ID: 11473870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of acute hypervolemic fluid infusion of hydroxyethyl starch and gelatin on hemostasis and possible mechanisms.
    Jin SL; Yu BW
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):91-8. PubMed ID: 19825916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis.
    Niemi TT; Kuitunen AH
    Acta Anaesthesiol Scand; 2005 Mar; 49(3):373-8. PubMed ID: 15752404
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A comparison of the haemodynamic effects of 4% succinylated gelatin, 6% hydroxyethyl starch (200/0.5) and 4% human albumin after cardiac surgery.
    Kuitunen A; Suojaranta-Ylinen R; Kukkonen S; Niemi T
    Scand J Surg; 2007; 96(1):72-8. PubMed ID: 17461317
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effects of plasma substitutes on hemostasis].
    Blanloeil Y; Trossaërt M; Rigal JC; Rozec B
    Ann Fr Anesth Reanim; 2002 Oct; 21(8):648-67. PubMed ID: 12471786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colloid-induced changes in bleeding following liver resection in the rat.
    Zoucas E; Göransson G; Bengmark S
    Res Exp Med (Berl); 1984; 184(4):251-8. PubMed ID: 6208585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is the use of hydroxyethyl starch as priming solution during cardiac surgery advisable? A randomized, single-center trial.
    Svendsen ØS; Farstad M; Mongstad A; Haaverstad R; Husby P; Kvalheim VL
    Perfusion; 2018 Sep; 33(6):483-489. PubMed ID: 29199540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using SONOCLOT.
    Konrad C; Markl T; Schuepfer G; Gerber H; Tschopp M
    Anesth Analg; 1999 Mar; 88(3):483-8. PubMed ID: 10071991
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the safety and tolerance of 6% hydroxyethyl starch (200/0.5) solution: a randomized, controlled epidemiology study.
    Bothner U; Georgieff M; Vogt NH
    Anesth Analg; 1998 Apr; 86(4):850-5. PubMed ID: 9539614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.